What Is Glutathione? How It Works, Its Forms, and How the Routes Compare

Glutathione (γ-Glu-Cys-Gly) exists in two states: reduced (GSH, the active form) and oxidized (GSSG, what's left after it's done its job). The ratio between them — the GSH:GSSG ratio — is one of the more useful proxies for cellular redox health. A high ratio means your antioxidant system is keeping up with demand. A low one means it isn't, and oxidative stress accumulates as a result.

The molecule earns its "master antioxidant" designation through four distinct roles:

• Direct scavenging. GSH donates an electron to neutralize superoxide radicals, hydroxyl radicals, hydrogen peroxide, and lipid peroxides. The sulfur group on cysteine is what makes this possible — it's the reactive site.
• Glutathione peroxidase substrate. GPx enzymes use GSH to reduce hydrogen peroxide and lipid hydroperoxides to harmless water and alcohols. GPx4, specifically, is the primary defense against lipid peroxidation and the ferroptosis cell-death pathway — a detail that's become more important as ferroptosis research has matured.
• Redox recycling. GSH donates electrons to regenerate ascorbic acid (vitamin C) and tocopherol (vitamin E) after they've been oxidized. This isn't a backup function — it's part of the reason vitamin C works as long as it does in tissue.
• Phase II conjugation. In the liver, glutathione S-transferases attach GSH to fat-soluble toxins and reactive metabolites, rendering them water-soluble and exportable. The acetaminophen mechanism is the clearest example: its reactive metabolite NAPQI is normally conjugated by GSH before it can cause damage. When GSH is depleted, NAPQI accumulates. That's the mechanism — not a claim, just chemistry.

Glutathione drops with age mainly because cells make less of it: in a small study, older adults had about half the red-blood-cell glutathione of younger adults and much lower synthesis rates (Sekhar et al., 2011). That's not the whole picture.

Three additional drivers matter:

Chronic oxidative burden. Illness, inflammation, and sustained stress keep glutathione in constant expenditure. The pool doesn't get depleted all at once — it gets drawn down faster than synthesis can keep up.

Alcohol. Glutathione synthesis is dysregulated in alcoholic liver disease (Lu, 2013), and the liver takes the worst of it because that's where most alcohol is processed.

Dietary insufficiency. Glutathione synthesis is limited by cysteine supply (Lu, 2013). Cysteine comes primarily from meat, eggs, whey protein, and cruciferous vegetables. Low protein intake — or high oxidative demand against a low-protein backdrop — constrains the raw materials the cell needs to rebuild its GSH pool. Sulforaphane (from broccoli) is studied as an Nrf2 activator that can upregulate the synthesis pathway, though the human data remains mostly early-stage.

Deficiency signs aren't dramatic or diagnostic on their own. What researchers observe in populations with chronically low GSH includes higher markers of oxidative stress (8-isoprostane, 8-OHdG), impaired immune function, and reduced mitochondrial efficiency. These are associations in the research literature, not a checklist for self-diagnosis.

When you swallow glutathione, the enzyme gamma-glutamyl transferase (GGT) in the gut and liver breaks much of it down into its amino acids. In an early study of seven healthy volunteers, a single 3-gram oral dose did not significantly raise blood glutathione (Witschi et al., 1992).

Daily use is a different story. In a 6-month randomized, placebo-controlled trial of 54 adults, oral glutathione raised blood glutathione: by 30 to 35% in red cells, plasma and lymphocytes at 1,000 mg a day, with levels back to baseline a month after stopping (Richie et al., 2015). So oral absorption is limited and slow, not zero.

Liposomal oral glutathione is the most studied workaround. In a small one-month pilot study of healthy adults, Sinha et al. (2018) in the European Journal of Clinical Nutrition reported higher glutathione levels in whole blood, red cells, plasma, and immune cells with daily liposomal oral glutathione (PMID 28853742). Only 12 people had their levels measured, and the study was funded by a liposomal glutathione maker. Liposomal encapsulation is designed to protect the peptide from breakdown; how much intact glutathione it delivers hasn't been measured directly.

The injectable route avoids gut breakdown: IV glutathione enters the bloodstream directly, and subcutaneous glutathione is absorbed from under the skin. That's the pharmacological argument for injection. No human trial shows it raises glutathione inside cells more than oral, and whether it helps a specific person is a question for a physician, not a blog post.

IV glutathione enters the bloodstream directly and needs a clinic visit; subcutaneous glutathione is absorbed from under the skin and can be self-administered at home after instruction, which is why the Protocol MD glutathione protocol uses it. Neither route has been shown superior in humans.

For the full comparison, see glutathione IV vs injection.

The evidence base is real enough to take seriously and incomplete enough to warrant calibration. For a plain-language rundown of the glutathione benefits people pursue it for, start there; here's the honest map of what the research shows.

Antioxidant support and cellular health. The mechanism is well-established, and daily oral glutathione has been shown to raise blood GSH and lower the oxidized-to-reduced glutathione ratio over six months (Richie et al., 2015). Comparable human data for injectable glutathione are lacking. Markers of oxidative stress — 8-isoprostane, protein carbonylation, oxidized LDL — are associated with depleted GSH states in the literature. Whether supplementation by any route improves health outcomes in otherwise healthy adults is unsettled.

Liver support and detoxification. Honda et al. (2017) in BMC Gastroenterology gave oral glutathione (300 mg a day for four months, after a three-month lifestyle run-in) to adults with fatty liver in an open-label, single-arm pilot study; among the 29 who finished, the liver enzyme ALT fell, but there was no placebo group (PMID 28789631). The mechanism (GSH depletion under oxidative stress; Phase II conjugation impairment) is coherent and well-described. "Detox" as a marketing category is where this gets misused — glutathione supports the body's natural detoxification pathways; it is not a cleanse, a flush, or a treatment for any liver condition. The mechanism is specific; the lifestyle claim is not. We make no disease-treatment claims, and individual response varies.

Immune system function. T-lymphocytes are glutathione-dependent for proper function. GSH status is associated with T-cell proliferation, NK cell activity, and cytokine production. A 2009 review in Autoimmunity Reviews surveys how glutathione modulates immune responses and how altered levels are linked to autoimmune conditions (Perricone et al., 2009). The mechanistic logic is solid. Large interventional trials in otherwise healthy populations are limited.

Skin pigmentation. Glutathione inhibits tyrosinase, the rate-limiting enzyme in melanin synthesis — GSH is thought to shift melanin production away from darker eumelanin toward lighter pheomelanin. Watanabe et al. (2014) in Clinical, Cosmetic and Investigational Dermatology tested a topical oxidized glutathione lotion against placebo in 30 healthy women and reported a lower skin melanin index on the treated side over 10 weeks (PMID 25378941). That was a small, manufacturer-run trial of a lotion, not of injections. Protocol MD does not position injectable glutathione as a skin-lightening product; the regulatory and ethical landscape around marketing injectable agents for skin tone is complex. The mechanism is worth understanding. The marketing application is one we're deliberately not making.

Protocol MD does not provide glutathione as a skin-whitening treatment or make cosmetic claims. A dermatology review found no evidence that IV glutathione lightens skin, and adverse effects from IV use led the Philippine FDA to warn against it (Sonthalia et al., 2016).

Energy and mitochondrial function. Mitochondria generate the highest intracellular oxidative load of any organelle. GSH protects mitochondrial membranes from lipid peroxidation. Whether supplementing glutathione improves energy in healthy adults has not been shown in controlled trials; it is a research question, not an indication.

Like any compounded injectable medication, glutathione injection carries risks that vary by individual. Side effects also differ by form: oral, subcutaneous injection and IV each carry a distinct profile. The short version:

Reported side effects include injection site reactions (redness, swelling, bruising), headache, dizziness, nausea, and in rare cases allergic or anaphylactic reactions. The more serious reports in the literature involve high-dose intravenous use for skin lightening (Sonthalia et al., 2016). For a breakdown by form, see glutathione side effects. Source, dose, patient population, and concurrent medications all change the picture.

Who should approach with caution or avoid: individuals with asthma (sulfite sensitivity is a consideration with some formulations), those who are pregnant or breastfeeding, patients on certain chemotherapy agents, and anyone with a known allergy to glutathione or compounding excipients. This is not a complete contraindication list. A licensed provider reviews your full history before any prescription is written.

The gray-market risk profile is categorically different. A vial from an online peptide supplier — regardless of what the label claims — bypasses the sterility controls, sourcing verification, pharmacist review, and physician oversight that a 503A compounding pharmacy provides. The question isn't just "is glutathione safe?" — it's "is this glutathione, from this source, at this dose, for this person's history, administered with proper technique, safe?" That's a clinical determination.

The safety picture for glutathione depends largely on dose, route, and oversight. At the antioxidant doses used under physician supervision, glutathione injections are generally well tolerated — the most common issue is a mild, temporary injection-site reaction. The serious adverse events you'll read about are reported mainly with high-dose intravenous skin-lightening use, which led the Philippine FDA to warn against it (Sonthalia et al., 2016). That is a different use case with a different risk profile. Compounded glutathione carries its own risk: in August 2026 the FDA reported at least 30 patients with adverse events after IV glutathione that compounding pharmacies had made from one lot of dietary-supplement-grade glutathione (FDA, 2026). Ingredient grade and sterility matter, which is why the pharmacy and its ingredient source matter. Glutathione is neither "dangerous" nor "perfectly safe"; the risk depends on how it's used and who's supervising it, which is why a physician review, an appropriate dose and a 503A-compounded product matter.

Before the first injection: Your physician reviews your intake, health history and current medications, and decides whether glutathione is appropriate. No prescription is written until then.

The injection itself (subcutaneous): Small-gauge needle, typically into the abdomen or thigh — similar technique to insulin administration. Most patients report minimal discomfort. Minor injection site reactions (redness, mild swelling) are the most common immediate response and typically resolve within hours.

In the days following: Many people notice little. Glutathione is not a stimulant, and no trial has shown a felt effect in healthy adults on any timeline.

Ongoing: Frequency, duration and any changes are set by your physician. Ask your care team how follow-up works for your plan.

Cost: Physician-prescribed compounded glutathione costs more than a supplement — that reflects the clinical process, pharmaceutical-grade sourcing, and provider oversight. Exact pricing depends on your protocol; a consultation is the right place to discuss that.

Both glutathione and NAD+ are central to cellular redox biology — and they're biochemically dependent in a way most coverage misses.

NADPH — the reduced form of nicotinamide adenine dinucleotide phosphate, synthesized downstream from NAD+ — is required by glutathione reductase to recycle GSSG back to its active form, GSH. In theory, if NADPH runs short, less glutathione is recycled to its active form even when synthesis is intact.

That is the rationale some protocols use for pairing them. Whether combining NAD+ and glutathione adds anything in humans has not been tested.

Explore Protocol MD's NAD+ protocol →

A disclosure first: Protocol MD sells physician-prescribed glutathione, so we have a commercial interest in this topic. Protocol MD's glutathione starts with a physician evaluation, not a checkout page. The clinical process:

• Complete intake — health history, medications, goals
• Physician review — case review, any testing the physician asks for, and a decision on whether treatment is appropriate
• Prescription dispensed only if appropriate, from a licensed 503A compounding pharmacy
• Follow-up with your care team; ask what the schedule is for your plan

The 503A distinction matters: compounded medications are prepared by a licensed compounding pharmacy under a valid patient-specific prescription, subject to USP <797> sterility standards. This is not the same regulatory framework as an FDA-approved drug — and we'll say that plainly. It's also not the same as an unlabeled vial from an online peptide supplier with a "not for human consumption" disclaimer. The difference is sterility testing, sourcing verification, physician oversight, and someone whose license is on the line reviewing your case before a prescription is written.

If a physician determines it's appropriate for you, physician-prescribed glutathione is dispensed from a 503A compounding pharmacy — never a gray-market vial.

View the Glutathione product page →

Start your free assessment →

Glutathione is a molecule every cell already makes and depends on; the human evidence for supplementing it, by any route, is mostly small and early, so whether injectable glutathione makes sense for you is a decision for a physician who has reviewed your history. For what to realistically expect over the first weeks, see glutathione before and after.